Presented By: Science, Technology, and Public, Policy; Ford School of Public Policy
“CAFTA, Intellectual Property, and Transnational Mobilization for Access to Medicines in Central America”
ANGELINA GODOY, Helen H. Jackson Chair in Human Rights and Director, Center for Human Rights, University of Washington
STPP LECTURE SERIES PRESENTS:
Monday, September 19
4:00-5:30 pm
1110 Weill Hall (Betty Ford Classroom)
735 S. State St., Gerald R. Ford School of Public Policy
Sponsored by: Herbert H. and Grace A. Dow Foundation
Co-sponsored by: Center for Global Health and the Center for Latin American & Caribbean Studies
In recent years, the application of intellectual property (IP) to pharmaceutical products has generated increasing controversy in many contexts around the world. Like other parts of Latin America, Central American countries were required to introduce reforms to their IP laws under the terms of the WTO’s TRIPS Agreement, and later by the ratification of their trade agreement with the United States, which required yet stricter provisions. In the context of discussions generated by the US-Dominican Republic-Central America Trade Agreement, health advocates argued that the new IP rules threatened developing countries’ ability to protect public health. While campaigns against CAFTA were ultimately unsuccessful in stopping the agreement, Godoy argues that they did achieve some important gains, and helped set the stage for subsequent struggles in South America. She also believes that they also offer important insights into the strengths and limitations of transnational advocacy for health rights in the context of IP reforms.
Monday, September 19
4:00-5:30 pm
1110 Weill Hall (Betty Ford Classroom)
735 S. State St., Gerald R. Ford School of Public Policy
Sponsored by: Herbert H. and Grace A. Dow Foundation
Co-sponsored by: Center for Global Health and the Center for Latin American & Caribbean Studies
In recent years, the application of intellectual property (IP) to pharmaceutical products has generated increasing controversy in many contexts around the world. Like other parts of Latin America, Central American countries were required to introduce reforms to their IP laws under the terms of the WTO’s TRIPS Agreement, and later by the ratification of their trade agreement with the United States, which required yet stricter provisions. In the context of discussions generated by the US-Dominican Republic-Central America Trade Agreement, health advocates argued that the new IP rules threatened developing countries’ ability to protect public health. While campaigns against CAFTA were ultimately unsuccessful in stopping the agreement, Godoy argues that they did achieve some important gains, and helped set the stage for subsequent struggles in South America. She also believes that they also offer important insights into the strengths and limitations of transnational advocacy for health rights in the context of IP reforms.
Related Links
Explore Similar Events
-
Loading Similar Events...
